SREBF1 and glioblastoma: Moreover, EGFR signaling binds to specific sites of the enhanced miRNA-29 promoter to increase its expression in GBM cells by upregulating SCAP/SREBP-1 whereas miRNA-29 can suppress SCAP and SREBP-1 expression to inhibit lipid synthesis in GBM (88, 89).